THE COVID-19 PANDEMIC AND THE USE OF PHARMACEUTICAL NANOTECHNOLOGY

Mahamuda Fatema, Nafisah Mahjabin*, Susmita Roy Ria, Furhatun-Noor, Md. Asadujjaman, Mohammad Taleb Hossain and Md. Harun Ar Rashid

ABSTRACT

As of right now, there is no effective treatment for COVID-19. Many medications that have been studied in recently as possible COVID-19 therapies have shown considerable toxicity and poor efficacy. Consequently, loaded medications can have their therapeutic effect enhanced and their toxicity reduced by the application of nanotechnology. We outlined the medications investigated as COVID-19 treatments in this review, along with the benefits of viral nanostructured drug delivery systems. Compared to free medicines, these systems have shown lower toxicity and improved antiviral efficacy. We think that in order to find effective COVID-19 therapies, this strategy should spur the development of innovative nanostructured drug delivery methods. Here we address the remaining obstacles in the way of approving such promising nano systems for therapeutic application.

Keywords: COVID-19, virus, nanotechnology, toxicity, therapy, pandemic etc.